|
We benefit significantly from the expertise
of the prestigious global R&D company, the
Johnson
& Johnson Pharmaceutical Research &
Development (PRD). We are committed
to providing innovative, cost effective,
knowledge-based products which improve health
and the quality of life, through encouraging
decentralised, entrepreneurial efforts and
active partnerships with companies inside
and outside our organisation.
Strong support
for innovative research
We place innovation at the centre
of our culture, reward it, create structures
to maximise it and fund significant internal
and external research. In the tradition
of functional autonomy, we are motivated
by an entrepreneurial spirit.
Commitment
to decentralised, entrepreneurial efforts
"Experience has taught us we're much
better off having small groups of dedicated
scientists working with as little bureaucracy
as possible and a sense of ownership and
accountability for the business. Let them
do their own thing and good things will
happen," states Johnson & Johnson CEO Ralph
Larsen. This decentralised approach to R&D
gives the companies freedom, flexibility
and resources to define their own priorities
and to collaborate as needed. We are all
bound together by the guiding principles
of the CREDO,
our statement of shared values.
Collaborative
relationships are key
Internal Collaboration
We maintain active partnerships with the companies
who market our products. We also work closely
with major centres of clinical development
through local operating companies worldwide.
The R&D technology infrastructure is being
enhanced to maximise all aspects of global
research and development. Common systems are
being developed for business critical processes,
including those supporting clinical research
and development, regulatory, pharmacovigilance
and the provision of electronic dossiers to
regulatory authorities.
External Collaborations
We develop valued partnerships with other
pharmaceutical and biotechnology companies,
academic institutions and technology vendors,
combining centres of excellence to our mutual
benefit.
|
